UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...

Early flooding hits Venice, Fla. Honda recalls nearly 1.7 million vehicles for steering problem that could lead to crashes ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...

Explore the significant advancements in early diagnosis and treatment of Gaucher disease, a common lysosomal storage disorder ...

Kathryn Thomas has reflected on rushing her daughter to the hospital after she contracted RSV at just three weeks old.

Africa's dependence on imported vaccines was starkly illustrated by the Covid pandemic. But faced with recurrent outbreaks of diseases ranging from yellow fever and diphtheria to cholera and mpox, ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, . Sanofi advances its ambition to protect ...